Os métodos termo-analíticos são ferramentas úteis na avaliação da compatibilidade entre fármacos e adjuvantes, com destaque à calorimetria exploratória diferencial. Neste trabalho foram avaliados a compatibilidade e o comportamento térmico entre a isoniazida e adjuvantes tecnológicos primários usualmente empregados em formas farmacêuticas sólidas. A compatibilidade foi examinada por meio da preparação de misturas físicas binárias do tipo fármaco/adjuvante. Foi investigada também a influência da granulação por via úmida e do processo de compactação para as misturas de isoniazida e adjuvantes com função de material de enchimento e carga e deslizante. A isoniazida apresentou um comportamento térmico não encontrado na literatura. Os adjuvantes avaliados foram: ácido esteárico, amido, celulose microcristalina, crospovidona, croscarmelose sódica, dióxido de silício coloidal estearato de magnésio, glicolato de amido sódico, hipromelose, lactose, manitol, polidona e talco. Para as misturas físicas, a maioria dos adjuvantes mostrou-se compatível com o fármaco em questão. Foram verificadas interações com o ácido esteárico, o glicolato de amido sódico, a lactose, o manitol e a povidona. A isoniazida mostrou a formação de uma mistura eutética com o manitol e de interação química com a lactose. A agregação por via úmida e o processo de compactação não mostraram influências adicionais na compatibilidade das misturas avaliadas. Os resultados observados foram confirmados por métodos não-térmicos como difratometria de raios X, espectroscopia de infravermelho e ressonância nuclear magnética. / Thermo-analytical methods, and specially Differential Scanning Calorimetry, are useful support for the evaluation of compatibility between drug substances and pharmaceutical excipients. In this work were studied the compatibility and the thermal behavior of isoniazid and pharmaceutical excipients, commonly used for the formulation of solid dosage forms. Colloidal silicon dioxide, corn starch, crospovidone, hypromellose, lactose, magnesium stearate, mannitol, microcrystalline cellulose, povidone, sodium croscarmellose, sodium starch glycolate, stearic acid and talc were the excipients employed in these experiments. The compatibility was analyzed testing binary physical drug/excipient admixtures. The effect of wet granulation and compression was also investigated, in this case especially between isoniazid, fillers and lubricant. For almost all excipients no incompatibilities with isoniazid were observed. Interactions were detected when the drug substance was added to stearic acid, sodium starch glycolate, lactose, mannitol and povidone. Isoniazid formed a euthetic mixture with mannitol, whereas a possible chemical reaction occurred between isoniazid and lactose. Wet granulation and compaction of the tested admixtures did not affect the results observed above. These observations were confirmed by non-thermal techniques, such as X-Ray diffractometry, infrared spectroscopy and nuclear magnetic resonance.

Submitted by Marlene Santos (marlene.bc.ufg@gmail.com) on 2018-07-31T20:20:23Z No. of bitstreams: 1 Tese - Luís Antônio Dantas Silva - 2017.pdf: 3852477 bytes, checksum: 3d70f0bfde2edb9fbe3baf236d1c369c (MD5) / Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2018-08-01T13:36:01Z (GMT) No. of bitstreams: 1 Tese - Luís Antônio Dantas Silva - 2017.pdf: 3852477 bytes, checksum: 3d70f0bfde2edb9fbe3baf236d1c369c (MD5) / Made available in DSpace on 2018-08-01T13:36:01Z (GMT). No. of bitstreams: 1 Tese - Luís Antônio Dantas Silva - 2017.pdf: 3852477 bytes, checksum: 3d70f0bfde2edb9fbe3baf236d1c369c (MD5) Previous issue date: 2017-04-07 / Fundação de Amparo à Pesquisa do Estado de Goiás - FAPEG / Introduction: Self-emulsifying drug delivery systems (SMEDDS) have been successfully used as carriers for poorly water-soluble drugs, because they can effectively solubilize them, as well as stimulate their intestinal lymphatic transport, reduce first-pass metabolism, and inhibit efflux proteins present in intestinal cells. All these effects together contribute to the improvement in the oral bioavailability of the incorporated drugs. The preparation of solid self-emulsifying systems is associated with additional advantages, such as increased stability, ease of transport, storage, and administration. Hot-melt extrusion is a technique that has attracted great interest in the pharmaceutical industry in recent years for enabling continuous production of solid dosage forms, with high productivity and low cost. In addition, it can be performed without the use of solvents. Despite this, there are no reports in the literature about the use of this technique in the production of solid self-emulsifying systems. Objectives: The objective of the present work was to perform preformulation studies and to develop solid self-microemulsifying systems containing carvedilol by hot-melt extrusion, aiming at improving the dissolution of this drug. Methods: Initially, carvedilol solubility and compatibility in different lipid excipients were determined, respectively, by the equilibrium solubility method and thermoanalytical, spectroscopic and isothermal stress techniques. An analytical method was developed and validated to carvedilol quantitation by high performance liquid chromatography. Next, the selected excipients were used in the construction of a ternary phase diagram, in order to determine the best ratio for SMEDDS production. Finally, the selected liquid formulation was mixed with a polymeric system consisting of an enteric polymer (hydroxypropylmethylcellulose acetate succinate) and other excipients. The resulting mixture was extruded in a twin screw hot-melt extruder. Box-Behnken factorial design was used to evaluate the effects of formulation (carvedilol concentration) and process variables (temperature and recirculation time) on the release of the drug (in 0.1 M HCl and phosphate buffer pH 6.8) and redispersion of the microemulsion from the solid system. The extrudates’ morphology was evaluated by light microscopy and scanning electron microscopy and the physical state of the drug in the preparation was investigated by differential scanning calorimetry and X-ray powder diffraction. Results: Preformulation studies showed that carvedilol is incompatible with the lauric acid, oleic acid, Gelucire® 44/14, Capmul® MCM, canola oil, castor oil, polyethoxylated castor oil, corn oil, soybean oil, sunflower oil and safflower oil. On the other hand, carvedilol was stable in mixtures with sesame oil, Plurol® Isostearique, Transcutol HP®, stearic acid, palmitic acid, Compritol® 888 ATO, Emulium® 22 and with the mixture of capric/caprilic triglycerides (CCT). The CCT showed to be the best solvent for carvedilol (3.93 ± 0.20 mg mL-1), among the compatible lipid excipients. Thus, the mixture of CCT, Plurol® and Transcutol HP® was selected for preparation of the self-emulsifying systems containing carvedilol. The phase diagram showed that the ratio of 50/37.5/12.5 (oil/surfactant/cosurfactant) resulted in the best parameters of self-emulsification (time, clarity and stability) average size (140.04 ± 7.22 nm) and size distribution (0.219 ± 0.011). These values were not significantly altered by the inclusion of carvedilol in the mixture (139.06 ± 7.28 nm and 0.221 ± 0.015). This self-microemulsifying concentrate with polymeric carriers were then extruded and the resulting product was a compact matrix. Factorial design showed that the drug concentration, temperature and recirculation time significantly influenced the drug release in different media, as well as the reconstitution efficiency of the microemulsion. Carvedilol release in acid medium was in the range of 12 to 25% and it was significantly affected by the temperature and recirculation time. The polymeric matrix was able to prevent redispersion of the system in acid. In turn, drug released was significantly affected by drug concentration in pH 6.8, ranging from 43 to 85%. Drug release in this medium was primarily affected by the concentration of the drug in the formulation. The reconstitution efficiency was significantly affected by the circulation time and process temperature, ranging from 55 to 100% in pH 6.8. Average size (145 to 164 nm) and PdI (0.209 to 0.262) were not significantly affected by the studied variables Conclusion: Self-microemulsifying extrudates were prepared from the lipid concentrate selected from the preformulation studies. The solid systems allowed a site-specific microemulsion redispersion, thus presenting potential for lymphatic absorption of carvedilol. The experimental results presented here are the first report about the production of solid self-microemulsifying systems containing carvedilol by hot-melt extrusion. / Introdução: Sistemas automicroemulsionáveis de liberação de fármacos (SMEDDS) têm sido empregados, com sucesso, como carreadores de fármacos pouco solúveis em água, pois conseguem solubilizá-los eficientemente, assim como podem estimular seu transporte linfático intestinal, reduzindo o metabolismo de primeira passagem e inibindo as proteínas de efluxo presentes nas células intestinais. Todos esses efeitos em conjunto contribuem para a melhora na biodisponibilidade oral dos fármacos incorporados. O preparo de sistemas automicroemulsionáveis sólidos está associado a vantagens adicionais, tais como o aumento da estabilidade, facilidade de transporte e armazenamento e maior conveniência de administração. A termoextrusão é uma técnica que tem atraído grande interesse na indústria farmacêutica nos últimos anos por possibilitar a produção contínua, com alta produtividade e baixo custo de formas sólidas, sendo ainda executada sem uso de solventes. Apesar disto, não existem relatos na literatura sobre o emprego dessa técnica na produção de sistemas automicroemulsionáveis sólidos. Objetivos: O presente trabalho teve como objetivo realizar estudo de pré-formulação e, em seguida, desenvolver termoextrusados automicroemulsionáveis contendo carvedilol, visando a melhora na dissolução deste fármaco. Métodos: Inicialmente, a solubilidade e compatibilidade do carvedilol em diferentes adjuvantes lipídicos foram determinadas, respectivamente, pelo método de solubilidade no equilíbrio e pelo emprego de técnicas termoanalíticas, espectroscópicas e de estresse isotérmico. A quantificação do carvedilol nestes estudos foi realizada por cromatografia a líquido de alta eficiência e, para tanto, o método analítico foi desenvolvido e validado. Em seguida, os adjuvantes selecionados foram utilizados na construção de um diagrama de fases ternário, no intuito de determinar a melhor proporção dos mesmos para o preparo de SMEDDS. Por fim, a formulação líquida selecionada foi misturada a um sistema polimérico constituído por polímero entérico (acetosuccinato de hidroxipropilmetilcelulose) e outros adjuvantes, sendo a mistura resultante processada por termoextrusão em extrusor de parafuso duplo. Planejamento fatorial do tipo Box-Behnken foi empregado para avaliar os efeitos de variáveis de formulação (concentração de carvedilol) e de processo (temperatura e tempo de recirculação) sobre a liberação do fármaco (em meio HCl 0,1 M e em tampão fosfato pH 6,8) e sobre a reconstituição da microemulsão a partir do sistema sólido. A morfologia dos termoextrusados foi avaliada por microscopia óptica e por microscopia eletrônica de varredura e o estado físico do fármaco na preparação foi investigado por calorimetria exploratória diferencial e difração de raios-X de pó. Resultados: Os estudos de pré-formulação mostraram que o carvedilol é incompatível com os adjuvantes ácido láurico, ácido oleico, Gelucire® 44/14, Capmul® MCM, óleo de canola, óleo de rícino, óleo de rícino polietoxilado, óleo de milho, óleo de soja, óleo de girassol e óleo de cártamo. Por outro lado, o carvedilol se mostrou estável nas misturas com o óleo de gergelim, Plurol® Isostearique, Transcutol HP®, ácido esteárico, ácido palmítico, Compritol® 888 ATO, Emulium® 22 e com a mistura de triglicerídeos dos ácidos cáprico e caprílico (TAC). O TAC mostrou ainda ser o melhor solvente para o carvedilol (3,93 ± 0,20 mg/mL), dentre os materiais oleosos compatíveis. Dessa forma, a mistura de TAC, Plurol® e Transcutol HP® foi selecionada para o preparo de sistemas automicroemulsionáveis. O diagrama de fases mostrou que a proporção 50/37,5/12,5 (óleo/tensoativo/cotensoativo) resultou nos melhores parâmetros de autoemulsificação (tempo, limpidez e estabilidade), tamanho médio (140,04 ± 7,22 nm) e distribuição de tamanho (0,219 ± 0,011). Esses valores não foram significativamente alterados pela inclusão do carvedilol na mistura (139,06 ± 7,28 nm e 0,221 ± 0,015). O concentrado automicroemulsionável, adicionado aos polímeros, contendo carvedilol foi então termoextrusado e o produto resultante apresentou matriz compacta. A concentração do fármaco, a temperatura de processamento e o tempo de recirculação influenciaram significativamente o perfil de liberação do fármaco nos diferentes meios, bem como a eficiência de reconstituição da microemulsão. A liberação do carvedilol em meio ácido esteve na faixa entre 12 e 25%, sendo significativamente afetada pela temperatura e tempo de recirculação. Em meio ácido, a matriz polimérica foi capaz de evitar a reconstituição da microemulsão. Por sua vez, em meio pH 6,8, a liberação do carvedilol foi maior e variou entre 43 e 85%, sendo afetada pela concentração do fármaco na formulação. Nesse meio, a eficiência de reconstituição foi significativamente afetada pelo tempo de recirculação e pela temperatura, apresentando eficiência de reconstituição na faixa entre 55 e 100%. O tamanho médio (145 a 164 nm) e PdI (0,209 a 0,262) das microemulsões não tiveram seus valores afetados significativamente pelas variáveis estudadas. Conclusão: Termoextrusados automicroemulsionáveis foram preparados a partir do concentrado lipídico composto por adjuvantes selecionados nos estudos de pré-formulação. Os sistemas sólidos conferiram reconstituição sítio-específica da microemulsão, apresentando assim potencial para proporcionar absorção linfática do carvedilol. Os achados experimentais aqui apresentados são o primeiro relato da obtenção de sistemas automicroemulsionáveis sólidos contendo carvedilol pela técnica de termoextrusão.

<div>Drug solubility is a persistent challenge in pharmaceutical product development. The objective of this research is to develop a formulation/processing strategy by means of a biodendrimeric solid dispersion (BDSD) platform, for increasing the solubility and dissolution rate of poorly water-soluble drugs. The BSDS platform combines a novel type of excipient, referred to as DLB, with a new application of the hot melt extrusion (HME) process.</div><div><br></div><div>Four model compounds – phenytoin (PHT), griseofulvin (GSF), ibuprofen (IBU), and loratadine (LOR) – were used to evaluate the solubilization effect of an octenylsuccinate-modified dendrimer-like biopolymer (OS-DLB). Shake-flask solubility measurements show that OS-DLB exerts significant solubilizing effect when present at less than 0.2% in water. The presence of hydrophobic C₈ chains on OS-DLB creates the type of favorable nonpolar microenvironment necessary for producing a parallel liquid phase equilibrium responsible for the increase in the total amount of drug dissolved in aqueous media. The higher the hydrophobicity of the drug, the higher the observed solubilization effect. Isothermal titration calorimetry studies show that drug solubilization by OS-DLB occurs by means of entropy-driven interactions. These studies also show that the intermolecular interaction between IBU and OS-DLB in solution exhibits very small energy change upon mixing but a stronger effect on entropy. In comparison, the intermolecular interaction between the less hydrophobic GSF and OS-DLB have significant effects on both enthalpy and entropy. Consequently, in terms of solubilization enhancement, it was found that the interaction between IBU and OS-DLB is entropy-driven (more favorable), while in the case of GSF, the interacting molecules are arranged to maximize enthalpic interaction.</div><div><br></div><div>Based on the solubility studies, a formulation/processing approach for enhancing the dissolution rate of the model drugs was developed. The biopolymer serving as both carrier and solubilizing agent, was coprocessed with poloxamer, functioning as a processing aid, using hot melt extrusion (HME) as an enabling technology. The result is a non-amorphous solid dispersion, exhibiting high and long-lasting supersaturation upon dissolution. A 3-factor, 3-level Box-Behnken design was implemented to define the optimal design space for the formulation/extrusion process. The results obtained from multivariate data analysis (partial least squares and principal components analysis) and response surface modeling suggest that drug release performance of IBU BDSDs is strongly influenced by the processing variables, while maximum release of GSF from the BDSDs can be attained through selective combination of functional excipients.<br></div>

<p>Therapeutic proteins are often lyophilized with excipients such as sucrose or trehalose to protect them during manufacturing and achieve a longer shelf-life. Formulation design for therapeutic proteins has been a trial-and-error process, and the mechanisms responsible for the stabilizing effects of excipients are not fully understood. Two proposed theories have been widely accepted: the water replacement theory and the vitrification theory.^1,2The water replacement theory suggests that excipients stabilize protein molecules in the solid state by forming hydrogen bonds that “replace” the hydrogen bonds to water that stabilize the protein in solution, while the vitrification theory asserts that proteins are stabilized by a glassy solid matrix of low mobility and does not require direct interactions between excipient and protein. A better understanding of the interactions between proteins and other components of the lyophilized matrix can facilitate rational formulation design and shorten the time in development. However, most of the analytical methods available can only provide information on the bulk properties of the lyophilized matrix such as moisture content and glass transition temperature (<i>T</i>_g); it has been difficult to measure the interactions between protein and excipient directly, if they exist. In order to characterize the interactions between protein and excipients in a lyophilized matrix with high resolution, a photolytic labeling method was developed in this dissertation, building on previous work in our research group. Photolytic labeling has long been used to identify protein-protein interactions <i>in vivo</i>.^3,4Common types of photo-reaction reagents and their applications are summarized in Chapter 1. The research described in this dissertation utilizes the diazirine functional group, which is activated after UV exposure and undergoes a free radical reaction to form covalent bonds with nearby molecules. The reaction can be used to identify the interactions between excipients and protein or peptide in a solid formulation. Previous studies in our lab have shown that photo-reaction can be applied to lyophilized solids to study protein-matrix properties and interactions in the solid.^5,6This dissertation seeks to further identify photo-reaction products and analyze them in a more quantitative way. </p><p> </p><p>Chapter 2 describes a quantitative analysis of photo-reaction products in solution and lyophilized solids using a model peptide, KLQ (Ac-QELHKLQ-NHCH₃). The purpose of the work in this chapter is to establish a quantitative analytical method for photo-reaction products, enabling studies of peptide-excipient interactions in lyophilized solids. KLQ was derivatized with a bifunctional probe NHS-diazirine (succinimidyl 4,4’-azipentanoate; SDA) at Lys5 to be photo-reactive. The SDA derivatized KLQ (KLQ-SDA) was used to study the photo-reaction products and examine excipient interactions. Identification and quantitation of photo-reaction products of KLQ-SDA was achieved with liquid chromatography mass spectrometry (LC-MS) and reversed phase HPLC (rp-HPLC). Important reaction products such as peptide-excipient adducts and peptide water adducts varied in different formulations. Unexpected reaction products such as unproductive “dead-end” products and peptide-phosphate adducts from buffer salt were also detected and quantified. Together, the photo-reaction products reflected the local environment near Lys5 of the peptide in the solid state. This study has provided a better understanding of photo-reaction with diazirine in the lyophilized solids together with a quantitative description of the local environment near Lys5. </p><p> </p><p>In Chapter 3, the photo-reaction products in lyophilized solids exposed to increasing moisture were analyzed, and the effect of increasing moisture on the local environment near the peptide was examined. Using the analytical method developed in Chapter 2, these studies explored whether peptide-water interactions, as measured by the formation of water adducts formed by photolytic labeling, are linearly correlated with an increase in solid bulk moisture content. Formulations containing the KLQ-SDA peptide were exposed to various relative humidity conditions and photolytic labeling was induced. Solids containing disaccharide excipients behaved differently from those containing amino acids when exposed to the same relative humidity condition, showing different levels of peptide-excipient and peptide-water adducts. With increasing moisture content in the solids, the formation of photo-reaction products did not mimic the pattern of solutions with same composition, indicating differences in the local environment. </p><p> </p><p>An alternative approach to studying lyophilized formulations using photolytic labeling is to incorporate photo-reactive excipients into the solid matrix. In Chapter 4, a new diazirine-labeled photo-excipient, photo-glucosamine (pGlcN), was chemically synthesized and incorporated into formulations of the therapeutic peptide salmon calcitonin (sCT) and compared with the commercially available diazirine-labeled amino acid, photo-leucine (pLeu). The studies in Chapter 4 further compared peptide-excipient interactions at the molecular level with two different photo-excipients, ionizable pLeu and unionizable pGlcN. Changing solution pH prior to lyophilization was expected to change ionic interactions between sCT and pLeu in the solid samples, resulting in different distributions of photo-reactions products; pH-dependent differences were not expected for pGlcN. The results demonstrated that the distribution of photo-reaction products varied with the composition of the formulation and the pH of the solution prior to lyophilization. The photo-reaction products in the pGlcN-containing formulation differed from those pLeu, showing a difference in the interactions of unionizable (pGlcN) and ionizable (pLeu) excipients with sCT in solid samples. </p><p> </p><p>The work in this dissertation has developed photolytic labeling as a tool to study lyophilized peptide formulations, and has provided a more quantitative understanding of the photo-reaction products that are produced from diazirine-labeled peptides or excipients in the solid state. A new photo-reactive excipient has also been presented (pGlcN), which showed different photo-reaction products than a commercially available photo-excipient (pLeu) and is promising for future study. Photolytic labeling for formulation development is still in its early stages, and additional research regarding reaction mechanism and complementary stability studies is needed. Nevertheless, the results presented in this dissertation support continued development of photolytic labeling as a practical method for formulation design and development. </p><p> </p>

Detta examensarbete dokumenterar arbetet med utveckling, införande och dokumentation av en nymetod för identitetsbestämning av farmaceutiska råvaror med röntgenfluorescens. Metoden ärutvecklad för att användas på laboratorier för kvalitetskontroll på AstraZeneca i Södertälje. Syftetmed arbetet var att utveckla en robust och effektiv metod samt att utbilda användarna i dethanteringssätt som krävs för att utföra snabba och korrekta analyser. Rapporten presenterarteknologin bakom röntgenfluorescensinstrument och vilka felkällor som kan påverka resultaten samtde pedagogiska teorier som använts för att beskriva det praktiska arbete som äger rum pålaboratoriet. Metoden och de försök som föregick metoden presenteras, och resultat och beslutdiskuteras. Hur utbildningen planerades, genomfördes och utvärderades presenteras också. / This master thesis is the documented work of the development, implementation and documentationof a new method for identification of pharmaceuticals excipients using X-ray fluorescence. Themethod is supposed to be used at the laboratory for quality control at AstraZeneca, Södertälje. Thepurpose of the thesis was to develop a stout and effective method and to educate the users in theskills needed to perform fast and correct analyses. This thesis presents the technology behind XRFinstruments and which sources of errors that could affect the results as well as the pedagogicaltheories used to describe the practical work that takes place at the laboratory. The method and theexperiment that preceded the method are presented, and the results and decisions are discussed.How the education was planned, performed and evaluated is also presented.

[pt] Diversas drogas administradas em neonatos possuem excipientes alcoólicos como etanol, álcool benzílico e propilenoglicol, que são potencialmente perigosos para o desenvolvimento do recém-nascido, principalmente se apresentarem fatores agravantes como prematuridade e baixo peso ao nascer. Foram selecionados estudos que utilizaram drogas com excipientes alcoólicos em neonatos em serviço hospitalar brasileiro. A lista de medicamentos contendo excipientes alcoólicos foi extraída da regulamentação da Agência Nacional de Vigilância Sanitária (ANVISA). Foram coletados dados relacionados à dose do medicamento, período de administração, número de recém-nascidos expostos, hospital responsável pela pesquisa e se esses bebês são a termo ou pré-termo. / [en] Several drugs administered to neonates have alcoholic excipients such as ethanol, benzyl alcohol and propylene glycol, which are potentially dangerous for the development of the newborn, especially if they present aggravating factors such as prematurity and low birth weight. Studies that used drugs with alcoholic excipients in neonates in the brazilian health system were selected. The list of drugs containing alcoholic excipients was extracted from the regulations of the National Health Surveillance Agency (ANVISA). Data related to the drug dose, period of administration, number of newborns exposed, hospital responsible for the research and whether these babies are term or preterm were collected.

La maladie d'Alzheimer (MA) est une maladie neurodégenerative qui risque de toucher plusieurs personnes dans les années à venir. Dans le cadre du projet de recherche, nous approchons le traitement de la MA par deux moyens : un traitement innovateur d'inhibition de la β-sécrétase et l'identification d'un facteur environnemental modifiable. Une stratégie intéressante afin de passer la barrière hémato-encéphalique serait de concevoir un système de transport de médicaments basé sur des immunoliposomes péguylés. En ce qui attrait à la prévention d'un facteur environnemental, nous avons étudié l'effet d'une diète en acides gras trans (AGT) sur un modèle de souris transgénique Alzheimer (3xTg-AD). D'une part, les travaux présentés dans ce mémoire ont porté sur les premières étapes de développement d'une formulation pharmaceutique dans le but d'inhiber la β-sécrétase au cerveau. D'autre part, les diètes en AGT n'ont pas démontré une incidence significative sur les marqueurs neuropathologiques d'un modèle animal Alzheimer

Made available in DSpace on 2014-12-17T14:25:22Z (GMT). No. of bitstreams: 1 MarcoVMN_TESE.pdf: 3982733 bytes, checksum: 381ae79721c75a30e3373fe4487512c7 (MD5) Previous issue date: 2014-02-05 / In this paper artificial neural network (ANN) based on supervised and unsupervised algorithms were investigated for use in the study of rheological parameters of solid pharmaceutical excipients, in order to develop computational tools for manufacturing solid dosage forms. Among four supervised neural networks investigated, the best learning performance was achieved by a feedfoward multilayer perceptron whose architectures was composed by eight neurons in the input layer, sixteen neurons in the hidden layer and one neuron in the output layer. Learning and predictive performance relative to repose angle was poor while to Carr index and Hausner ratio (CI and HR, respectively) showed very good fitting capacity and learning, therefore HR and CI were considered suitable descriptors for the next stage of development of supervised ANNs. Clustering capacity was evaluated for five unsupervised strategies. Network based on purely unsupervised competitive strategies, classic "Winner-Take-All", "Frequency-Sensitive Competitive Learning" and "Rival-Penalize Competitive Learning" (WTA, FSCL and RPCL, respectively) were able to perform clustering from database, however this classification was very poor, showing severe classification errors by grouping data with conflicting properties into the same cluster or even the same neuron. On the other hand it could not be established what was the criteria adopted by the neural network for those clustering. Self-Organizing Maps (SOM) and Neural Gas (NG) networks showed better clustering capacity. Both have recognized the two major groupings of data corresponding to lactose (LAC) and cellulose (CEL). However, SOM showed some errors in classify data from minority excipients, magnesium stearate (EMG) , talc (TLC) and attapulgite (ATP). NG network in turn performed a very consistent classification of data and solve the misclassification of SOM, being the most appropriate network for classifying data of the study. The use of NG network in pharmaceutical technology was still unpublished. NG therefore has great potential for use in the development of software for use in automated classification systems of pharmaceutical powders and as a new tool for mining and clustering data in drug development / Neste trabalho foram estudadas redes neurais artificiais (RNAs) baseadas em algoritmos supervisionados e n?o supervisionados para emprego no estudo de par?metros reol?gicos de excipientes farmac?uticos s?lidos, visando desenvolver ferramentas computacionais para o desenvolvimento de formas farmac?uticas s?lidas. Foram estudadas quatro redes neurais artificiais supervisionadas e cinco n?o supervisionadas. Todas as RNAs supervisionadas foram baseadas em arquitetura de rede perceptron multicamada alimentada ? frente (feedfoward MLP). Das cinco RNAs n?o supervisionadas, tr?s foram baseadas em estrat?gias puramente competitivas, "Winner-Take- All" cl?ssica, "Frequency-Sensitive Competitive Learning" e "Rival-Penalize Competitive Learning" (WTA, FSCL e RPCL, respectivamente). As outras duas redes n?o supervisionadas, Self- Organizing Map e Neural Gas (SOM e NG) foram baseadas estrat?gias competitivo-cooperativas. O emprego da rede NG em tecnologia farmac?utica ? ainda in?dito e pretende-se avaliar seu potencial de emprego como nova ferramenta de minera??o e classifica??o de dados no desenvolvimento de medicamentos. Entre os prot?tipos de RNAs supervisionadas o melhor desempenho foi conseguido com uma rede de arquitetura composta por 8 neur?nios de entrada, 16 neur?nios escondidos e 1 neur?nio de sa?da. O aprendizado de rede e a capacidade preditiva em rela??o ao ?ngulo de repouso (&#945;) foi deficiente, e muito boa para o ?ndice de Carr e fator de Hausner (IC, FH). Por esse motivo IC e FH foram considerados bons descritores para uma pr?xima etapa de desenvolvimento das RNAs supervisionadas. As redes, WTA, RPCL e FSCL, foram capazes de estabelecer agrupamentos dentro da massa de dados, por?m apresentaram erros grosseiros de classifica??o caracterizados pelo agrupamento de dados com propriedades conflitantes, e tamb?m n?o foi poss?vel estabelecer qual o crit?rio de classifica??o adotado. Tais resultados demonstraram a inviabilidade pr?tica dessas redes para os sistemas estudados sob nossas condi??es experimentais. As redes SOM e NG mostraram uma capacidade de classifica??o muito superior ?s RNAs puramente competitivas. Ambas as redes reconheceram os dois agrupamentos principais de dados correspondentes ? lactose (LAC) e celulose (CEL). Entretanto a rede som demonstrou defici?ncia na classifica??o de dados relativos aos excipientes minorit?rios, estearato de magn?sio (EMG), talco (TLC) e atapulgita (ATP). A rede NG, por sua vez, estabeleceu uma classifica??o muito consistente dos dados e resolveu o erro de classifica??o apresentados pela rede SOM, mostrando-se a rede mais adequada para a classifica??o dos dado do presente estudo. A rede Neural Gas, portanto, mostrou- se promissora para o desenvolvimento de softwares para uso na classifica??o automatizada de sistemas pulverulentos farmac?uticos

nÃo hà / Neonatos internados em unidade de terapia intensiva neonatal (UTIN) sÃo expostos a uma grande variedade de medicamentos, a maioria sem dados de seguranÃa e eficÃcia. Descrever o perfil de uso de medicamentos em neonatos em UTIN de um hospital pÃblico no Brasil de acordo com dados de registro do medicamento e potencial nocivo destes, foi o objetivo do trabalho. Trata-se de um estudo descritivo retrospectivo sobre uso de medicamentos em UTIN, envolvendo neonatos internados por mais de 24 horas e dados de prescriÃÃo coletados em prontuÃrio eletrÃnico durante o perÃodo de janeiro a junho do ano de 2012. InformaÃÃes sobre os medicamentos, com base nas bulas, foram comparadas com o British National Formulary for Children 2012-2013 e a base de dados Thomson Micromedex. O potencial nocivo de medicamentos e excipientes foi avaliado conforme a literatura. Neonatos foram categorizados em grupos de idade gestacional (IG). Os dados foram submetidos à anÃlise descritiva e testes de distribuiÃÃo (ANOVA, Teste U de Mann-Whitney, Kruskal-Wallis, qui-quadrado de Pearson) por IG com o nÃvel de significÃncia de p < 0,05. IncluÃram-se 192 neonatos, a maioria prÃ-termo, com mediana de 33 semanas de IG, totalizando 3.617 neonatos-dia. Registraram-se 3.290 prescriÃÃes, mÃdia 17,1 prescriÃÃes/neonato (DP  17,9) e 8,8 medicamentos/neonato (DP  5,9), maiores em neonatos mais imaturos (p < 0,05). Anti-infecciosos de uso sistÃmico, medicamentos para o sangue e ÃrgÃos formadores do sangue, trato alimentar e metabolismo apresentaram maior utilizaÃÃo, variando conforme a IG. Neonatos apresentaram maior exposiÃÃo a gentamicina seguido por ampicilina, heparina e fitomenadiona. A maioria dos neonatos (99,5%) foi exposta a medicamentos nÃo licenciados (NL) e de uso nÃo padronizado (NP), mais frequentes em neonatos com IG < 28 semanas (p < 0,05). Mais de 70% dos RN estiveram expostos a algum medicamento potencialmente perigoso (MPP), com maior frequÃncia em neonatos com IG < 31 semanas (p < 0,05). Praticamente todos os neonatos estiveram expostos a excipientes nocivos (EN) e potencialmente nocivos, sendo maior o nÃmero de formulaÃÃes prescritas a neonatos mais imaturos. Metilparabeno, propilparabeno e polissorbato 80 foram os EN aos quais os neonatos estiveram mais expostos, principalmente nas formulaÃÃes de domperidona soluÃÃo oral, polivitamÃnicos soluÃÃo oral e fentanila soluÃÃo injetÃvel. Neonatos em UTIN no Brasil, tal como em outras realidades, estÃo expostos a uma variedade de medicamentos NL, NP e com potencial nocivo, uma situaÃÃo preocupante. Alternativas seguras e estudos sÃo necessÃrios sobre esse tema. / Neonates admitted to neonatal intensive care unit (NICU) are exposed to a wide variety of drugs most without data on safety and efficacy. To describe the drug use profile of neonates in NICU of a public hospital in Brazil according to the drugs records and harmful potential of drugs and pharmaceutical excipients. Descriptive and retrospective study of drug use in NICU, with neonate inpatients for over 24 hours and prescription data from electronic medical records over the period from January to June, 2012. Drug information found in the package leaflets were compared with information in the British National Formulary for Children 2012-2013 and in the Thomson Micromedex database. The drug and excipients harmful potential was evaluated according to the literature. Neonates were categorized into groups of gestational age (GA). The data were analyzed using descriptive analysis and Distribution tests tests (ANOVA Mann-Whitney U, Kruskal-Wallis and Pearson's chi-squared) by GA, with a significance level of p <0.05. Were included 192 neonates, most preterm with median 33 weeks of GA and a total of 3.617 neonates-day. Were registered 3,290 prescriptions, average 17.1 prescriptions/neonate (SD  17.9) and 8.8 drugs/neonate (SD  5.9), higher in most immature neonates (p < 0.05). The anti-infectives for systemic use, blood and blood forming organs, alimentary tract and metabolism drugs groups showed increased use among the neonates, varying according to the GA. Neonates had higher exposure to gentamicin followed by ampicillin, heparin and phytomenadione. Most neonates (99.5%) were exposed to unlicensed drugs (UL) and off label use (OL), more frequently those with GA < 28 weeks (p < 0.05). More than 70% of the neonates were exposed to any high-alert medications, with higher frequency among neonates with GA < 31 weeks (p < 0.05). Almost all neonates were exposed to harmful and potentially harmful excipients, being greater the number of formulations prescribed to more immature neonates. Gentamicin (sulfate) injectable Solution 10 mg/mL (1 mL), fentanyl solution injectable 0.05 mg/mL (10 mL) and sodium heparin injectable solution were the containing harmful excipients formulations to which neonates were most exposed. Neonates in Brazilian NICU, as in other settings, are exposed to a variety of OL, UL and potentially harmful drugs and harmful excipients, an alarming situation. Safety alternatives and more studies are needed on this topic.

This dissertation has focused on studying the effect of four glycine derivatives on the solid state properties of mannitol, glycine, and sucrose when freeze dried into blended mixtures. The primary goal was to assess their value for use in the stabilisation of vaccines in the solid state, by examining key physical and chemical characteristics, which have been documented to be beneficial to the stabilisation of biopharmaceutical formulations. The novel excipients; dimethyl glycine, and trimethyl glycine, were shown to retard the crystallisation and increase the overall glass transition temperature, of mannitol, when freeze dried as evidenced by DSC and Powder X-ray diffraction. Mannitol’s glass transition temperature increased from 100C to 12.650C and 13.610C when mixed with methyl-glycine and dimethyl glycine respectively. The glycine derivatives did not show the same effect on sucrose which remained amorphous regardless of the concentration of the other excipient. The different behaviour with the sucrose system was thought to be due to relatively high glass transition temperature of sucrose. Conversely glycine remained highly crystalline due it’s relatively low glass transition temperature. The novel excipient formulations were also assessed for their effect on the aggregation of the adjuvant aluminium hydroxide when freeze dried by Dynamic Light Scattering (DLS).The formulations containing the glycine derivatives all caused a decrease in the aggregation size of the adjuvant from ~26 μm, to 185 nm in the presence of methyl glycine. The effects of lysozyme and viral antigen on the adjuvants were also examined showing that the addition of the virus did not affect the size of the aggregates formed, however lysozyme showed significant decreases in the aggregates formed. Examination of the freezing method were also made showing that faster freezing rates produced smaller aggregates of the adjuvant. When investigating the rate at which the excipients lost water during secondary drying there was evidence of the formation of hydrates of glycine, trimethyl glycine, and mannitol has shown that the glycine derivatives have attributes which would be beneficial in stabilising vaccines in the solid state when freeze dried.